Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q3 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Vivos Third Quarter 2025 Conference Call.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Connective Capital Management Rob Romero | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.53 | 14,000 | $7,420.00 | 86,521 | 2023-06-20 | Filing | |
| $0.53 | 5,000 | $2,650.00 | 72,521 | 2023-06-16 | Filing | |
| $0.54 | 10,000 | $5,400.00 | 67,521 | 2023-06-16 | Filing | |
| $0.50 | 21 | $10.50 | 57,521 | 2023-06-15 | Filing | |
| $0.49 | 10,000 | $4,900.00 | 57,500 | 2023-06-14 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 304,161 | $617,447 | 0% | |
| 2. | 115,907 | $235,291 | 0.01% | |
| 3. | 56,287 | $114,262 | 0% | |
| 4. | 43,531 | $88,368 | 0% | |
| 5. | 40,500 | $82,220 | 0% |